C12N2750/14041 - CPC Classification Index

ClassID:

110521 ⎘

C12N2750/14041 - CPC Classification

Classification description:

ssDNA viruses; Details; Parvoviridae Use of virus, viral particle or viral elements as a vector

Sub-classes:

C12N2750/14042 » virus or viral particle as vehicle, e.g. encapsulating small organic molecule 8
C12N2750/14043 » viral genome or elements thereof as genetic vector 56
C12N2750/14044 » Chimeric viral vector comprising heterologous viral elements for production of another viral vector 0
C12N2750/14045 » Special targeting system for viral vectors 6

Recent Application in this class:

20250381308

2025-12-18

AAV-MEDIATED EXPRESSION USING A SYNTHETIC PROMOTER AND ENHANCER

20240368564

2024-11-07

SUSPENSION SYSTEM FOR ADENO ASSOCIATED VIRUS PRODUCTION

20240066147

2024-02-29

AAV-MEDIATED EXPRESSION USING A SYNTHETIC PROMOTER AND ENHANCER

20230193214

2023-06-22

Suspension system for adeno associated virus production

20210008227

2021-01-14

GENE THERAPY FOR SPINAL CORD DISORDERS

20200306387

2020-10-01

Gene therapy for neurometabolic disorders

20200270583

2020-08-27

Suspension system for adeno associated virus production

20190083657

2019-03-21

AAV-mediated expression using a synthetic promoter and enhancer

20180171357

2018-06-21

Self-limiting viral vectors encoding nucleases

#10

20150017121

2015-01-15

COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY

#11

20140356327

2014-12-04

Gene therapy for neurometabolic disorders

#12

20090069261

2009-03-12

Gene therapy for spinal cord disorders

#13

20080292593

2008-11-27

GENE THERAPY FOR SPINAL CORD DISORDERS